162 related articles for article (PubMed ID: 32487106)
1. Performance of ultrasonography screening for breast cancer: a systematic review and meta-analysis.
Yang L; Wang S; Zhang L; Sheng C; Song F; Wang P; Huang Y
BMC Cancer; 2020 Jun; 20(1):499. PubMed ID: 32487106
[TBL] [Abstract][Full Text] [Related]
2. Early detection of breast cancer: benefits and risks of supplemental breast ultrasound in asymptomatic women with mammographically dense breast tissue. A systematic review.
Nothacker M; Duda V; Hahn M; Warm M; Degenhardt F; Madjar H; Weinbrenner S; Albert US
BMC Cancer; 2009 Sep; 9():335. PubMed ID: 19765317
[TBL] [Abstract][Full Text] [Related]
3. Rethinking screening mammography in Japan: next-generation breast cancer screening through breast awareness and supplemental ultrasonography.
Uematsu T
Breast Cancer; 2024 Jan; 31(1):24-30. PubMed ID: 37823977
[TBL] [Abstract][Full Text] [Related]
4. Screening for breast cancer.
Elmore JG; Armstrong K; Lehman CD; Fletcher SW
JAMA; 2005 Mar; 293(10):1245-56. PubMed ID: 15755947
[TBL] [Abstract][Full Text] [Related]
5. Cross-national comparison of screening mammography accuracy measures in U.S., Norway, and Spain.
Domingo L; Hofvind S; Hubbard RA; Román M; Benkeser D; Sala M; Castells X
Eur Radiol; 2016 Aug; 26(8):2520-8. PubMed ID: 26560729
[TBL] [Abstract][Full Text] [Related]
6. Pearls and Pitfalls of Interpretation of Automated Breast US.
Huppe AI; Inciardi MF; Aripoli AM; Peterson JK; Smith CB; Winblad OD
Radiographics; 2023 Oct; 43(10):e230023. PubMed ID: 37792592
[TBL] [Abstract][Full Text] [Related]
7. Early performance measures following regular versus irregular screening attendance in the population-based screening program for breast cancer in Norway.
Thy JE; Larsen M; Vigeland E; Koch H; Hovda T; Hofvind S
J Med Screen; 2024 Jun; 31(2):107-114. PubMed ID: 37691575
[TBL] [Abstract][Full Text] [Related]
8. Radiological features of screening-detected and interval breast cancers and subsequent survival in Eastern Finnish women.
Nykänen A; Sudah M; Masarwah A; Vanninen R; Okuma H
Sci Rep; 2024 May; 14(1):10001. PubMed ID: 38693256
[TBL] [Abstract][Full Text] [Related]
9. Cancer detection rate of breast-MR in supplemental screening after negative mammography in women with dense breasts. Preliminary results of the MA-DETECT-Study after 200 participants.
Kaiser C; Wilhelm T; Walter S; Singer S; Keller E; Baltzer PAT
Eur J Radiol; 2024 Apr; 176():111476. PubMed ID: 38710116
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design.
Ohuchi N; Ishida T; Kawai M; Narikawa Y; Yamamoto S; Sobue T
Jpn J Clin Oncol; 2011 Feb; 41(2):275-7. PubMed ID: 21131295
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of mammography and ultrasound in breast cancer: a systematic review and meta-analysis.
Tadesse GF; Tegaw EM; Abdisa EK
J Ultrasound; 2023 Jun; 26(2):355-367. PubMed ID: 36696046
[TBL] [Abstract][Full Text] [Related]
12. Can the Clinical Utility of iBreastExam, a Novel Device, Aid in Optimizing Breast Cancer Diagnosis? A Systematic Review.
Bhimani F; Zhang J; Shah L; McEvoy M; Gupta A; Pastoriza J; Shihabi A; Feldman S
JCO Glob Oncol; 2023 Sep; 9():e2300149. PubMed ID: 38085036
[TBL] [Abstract][Full Text] [Related]
13. Artificial Intelligence Improves Detection of Supplemental Screening Ultrasound-detected Breast Cancers in Mammography.
Yoen H; Chang JM
J Breast Cancer; 2023 Oct; 26(5):504-513. PubMed ID: 37704383
[TBL] [Abstract][Full Text] [Related]
14. Breast Cancer Screening: Can We Justify Deescalation?
Jatoi I
Cancer Epidemiol Biomarkers Prev; 2024 May; 33(5):638-640. PubMed ID: 38689574
[TBL] [Abstract][Full Text] [Related]
15. Ultrasonography is an effective tool for breast cancer screening in individuals with severe motor and intellectual disabilities.
Miyashita Y; Yanagida K; Shirafuji N; Hoshide R; Sato K; Taku K; Nakamura K
J Appl Res Intellect Disabil; 2024 May; 37(3):e13234. PubMed ID: 38561919
[TBL] [Abstract][Full Text] [Related]
16. Comparison of phenomics and cfDNA in a large breast screening population: the Breast Screening and Monitoring Study (BSMS).
Stebbing J; Takis PG; Sands CJ; Maslen L; Lewis MR; Gleason K; Page K; Guttery D; Fernandez-Garcia D; Primrose L; Shaw JA
Oncogene; 2023 Mar; 42(11):825-832. PubMed ID: 36693953
[TBL] [Abstract][Full Text] [Related]
17. US expert panel says breast cancer screening should begin at 40.
Tanne JH
BMJ; 2024 May; 385():q1020. PubMed ID: 38702065
[No Abstract] [Full Text] [Related]
18. Population-based screening for cancer: hope and hype.
Shieh Y; Eklund M; Sawaya GF; Black WC; Kramer BS; Esserman LJ
Nat Rev Clin Oncol; 2016 Sep; 13(9):550-65. PubMed ID: 27071351
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of recommendations on screening strategies for breast cancer due to hereditary predisposition: Who, When, and How?
Cai Y; Li J; Gao Y; Yang K; He J; Li N; Tian J
Cancer Med; 2021 May; 10(10):3437-3448. PubMed ID: 33932123
[TBL] [Abstract][Full Text] [Related]
20. Breast Tomographic Ultrasound: The Spectrum from Current Dense Breast Cancer Screenings to Future Theranostic Treatments.
Littrup PJ; Mehrmohammadi M; Duric N
Tomography; 2024 Apr; 10(4):554-573. PubMed ID: 38668401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
